Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Not Yet Recruiting

A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC

NCT06672068

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer

NCT06746870

Conditions: NSCLC, TNBC
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors

NCT06739031

Conditions: NSCLC
Locations: Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

View Trial Details

Not Yet Recruiting

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

NCT06735508

Conditions: NSCLC
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients.

NCT06736561

Conditions: ALK Positive, Ensartinib, NSCLC, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor

NCT06218069

Conditions: NSCLC
Locations: Eberhard Karls Universitaet Tuebingen (EKUT) Tübingen, Germany

Radboud University Medical Center (Radboudumc) Nijmegen, Gelderland, Netherlands

View Trial Details

Not Yet Recruiting

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

NCT06685653

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)

NCT06684873

Conditions: Brain Metastasases, NSCLC
Locations: Sun Yat-Sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study

NCT06652555

Conditions: ALK, NSCLC
Locations: Not specified

View Trial Details

Not Yet Recruiting

Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib

NCT06644495

Conditions: NSCLC
Locations: Not specified

View Trial Details